1. Introduction {#s0005}
===============

Stroke is among the leading causes of death in the world and a common cause of disability ([@bb0030], [@bb0015]). Its incidence is rising with increasing life expectancy, although about 20% of strokes occur before the age of 65. Ischemic stroke (IS) is a heterogeneous multi-factorial, polygenic, complex disease resulting from the combination of vascular, environmental and genetic factors ([@bb0060]). Inflammation and genetics are both prominent mechanisms in the pathogenesis of ischemic stroke ([@bb0055]). Candidate genes, stroke susceptible alleles and their association with stroke pathogenesis have been intensively studied in the last few years ([@bb0020], [@bb0040], [@bb0110]).

Numerous epidemiological studies in twins and families have revealed that the genetic factors in addition to other risk factors are involved in the predisposition of stroke. Recent findings have suggested that variations in the pro and anti-inflammatory cytokine genes may be associated with the risk of stroke. The genes encoding interleukin-1α (IL-1α), CD14 cell surface glycoprotein (CD14), galectin-2-encoding gene (LGALS2) and proteasome subunit type 6 (PSMA6), all of which are involved in the inflammatory mechanisms, were reported to be involved in the pathogenesis of cerebrovascular diseases ([@bb0110], [@bb0095], [@bb0115], [@bb0120], [@bb0025]).

CD14 is a receptor for bacterial lipopolysaccharide (LPS, endotoxin), and it mediates cell activation by LPS, while IL-1α acts as a proinflammatory cytokine which contributes to atherogenesis. Increased activity of PSMA6 activates the nuclear factor КB (NF-КB). (NF-КB) is a central transcription factor that regulates the expression of the genes of adhesion molecules and cytokines which are involved in atherogenesis. LGALS2 gene C3279T is encoded by galectin-2 which is thought to reduce the transcriptional level of galectin-2, and also play a role in protection against myocardial infarction. The single nucleotide polymorphisms (SNPs) present in the genes CD14 (-C260T), IL-1α (-C511T, -C889T), LGALS2 (-C3279T) and PSMA6 (-C8G) respectively, were found to be associated with increased risk of cardiovascular diseases in different populations, but limited studies have been published so far examining these SNPs and their association with susceptibility for IS.

Since a single study may not prove to be sufficient in providing reliable conclusions because of the presence of small amounts of subjects and weight age of statistical and clinical heterogeneities, therefore, we carried out this meta-analysis, which combines the eligible published literatures based on quantitative synthesis to obtain a more convincing assessment of the association between these inflammatory gene polymorphisms and risk of IS.

2. Materials and methods {#s0010}
========================

2.1. Identification of relevant studies {#s0015}
---------------------------------------

A literature search for eligible candidate gene studies published before August 31, 2015 was conducted in the PubMed, Medline, EMBASE, OVID and Google Scholar databases. The following combinations of main keywords were used: ('Interleukin-1 alpha' or 'IL-1α' or 'IL1F1') and ('CD14 cell surface glycoprotein' or 'CD14') and ('Galectin-2-encoding gene' or 'LGALS2' or 'HL14') and ('proteasome subunit type 6' or 'PSMA6') and ('ischemic stroke' or 'cerebral infarction' or 'IS') and ('genetic polymorphism' or 'single nucleotide polymorphisms' or 'SNP'). Fixed or random effects models were used to estimate the Pooled Odds ratio (OR) and 95% confidence interval (CI). Begg\'s funnel plot was used to assess the publication bias in the studies. Meta-analysis was carried out by using RevMan 5.3 software.

3. Inclusion and exclusion criteria {#s0020}
===================================

To be included in the analysis, eligible studies have to meet the following criteria: (1) case--control studies on the association between the IL-1α (-C889T or -C511T); CD14 (-C260T); LGALS2 (-C3279T); PSMA6 (-C8G) genetic polymorphisms and susceptibility to IS; (2) all patients in the candidate studies meet the diagnostic criteria for IS; (3) studies with sufficient available data to calculate ORs with corresponding 95% CIs. The major reasons for excluding studies were: (1) not a case--control study; (2) duplicate publications with overlapping subjects from the same study; and (3) no available data reported. This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline ([@bb0085]). No author was contacted regarding the missing information that was required for the meta-analysis to avoid the risk of retrieval bias.

4. Data extraction {#s0025}
==================

According to the PRISMA guidelines, two investigators independently SM and PK checked each full-text report for eligibility and extracted the following data from eligible studies: surname of first author, year of publication, country of origin, ethnicity, definition and number of case and control, age, sex ratio, genotyping method and genotype frequency, etc. Disagreements were solved by discussion between all authors until consensus was reached.

5. Quality assessment {#s0030}
=====================

We also evaluated the methodological quality of every study which is included in our analysis using a quality assessment scale developed for genetic association studies ([@bb0005]) which was modified by us to increase the relevance of our study. This scale took into account both traditional epidemiological considerations and genetic issues. The scores ranged from 0 (worst) to 16 (best). Details of the scale are presented in [Table 1](#t0005){ref-type="table"}. Two authors independently assessed the quality of included studies. Discrepancies over quality scores were resolved by discussion among all the authors and subsequent consensus was reached.

6. Statistical analysis {#s0035}
=======================

Genotype distributions in the controls were tested for confirmation to Hardy--Weinberg equilibrium (HWE) using the chi-square test. The association between the inflammatory genetic polymorphisms and susceptibility to IS was assessed by the pooled OR with their corresponding 95% CI under two genetic models, including dominant and recessive models. Taking into consideration possible heterogeneity between-study, a statistical test for heterogeneity was first conducted using Cochran\'s Q statistic and I^2^ metric ([@bb0045]). We considered the presence of significant heterogeneity at the 10% level of significance and values of I^2^ exceeding 50% as an indicator of significant heterogeneity. When no heterogeneity was found with P \< 0.10 or I^2^, 50%, a fixed-effect model was used to estimate the pooled ORs and 95% CIs. Otherwise, a random-effect model was applied. Begg\'s funnel plot was used to assess the potential for publication bias.

7. Results {#s0040}
==========

A total of 99 published articles were identified by using the pre-specified search strategy. [Fig. 1](#f0005){ref-type="fig"} depicts a flow chart of both the retrieved and excluded studies with their reasons for exclusion. Out of 99 retrieved articles, 42 studies were excluded due to its irrelevancy to our interest and 9 studies were excluded as they were in duplicate records. Keeping the inclusion criteria in mind, 21 case--control studies were included in our meta-analysis. Studies were carried out in two major ethnic populations; 9 studies were in Asian and the other 11 studies were in Caucasian population. The publication years of the included studies ranged from 2000 to 2013. 17 studies in this meta-analysis had controls in HWE. The quality scores of all included studies were moderately high. Out of 21 studies, 8 studies had hospital based and 13 studies had population based source of controls. Begg\'s funnel plot suggested significant publication bias in the studies ([Fig. 3](#f0015){ref-type="fig"}). [Table 2](#t0010){ref-type="table"} gives a summary of the characteristics and methodological quality of all the included studies.

7.1. IL-1α gene polymorphism with the susceptibility of IS {#s0045}
----------------------------------------------------------

For C889T, six case--control studies with a total of 2809 IS patients and 2854 controls showed a non-significant association with susceptibility to IS under dominant \[TT + TC vs. CC: OR = 1.18, 95% CI: 0.67--2.08, P = 0.58\], and recessive models \[TT vs. CC + TC: OR = 1.15, 95% CI: 0.82--1.62, P = 0.43\] ([Fig. 2](#f0010){ref-type="fig"}).

For C511T, 10 case--control studies with a total of 2718 IS patients and 2748 controls showed a non-significant association with susceptibility to IS under dominant \[TT + TC vs. CC: OR = 0.95, 95% CI: 0.66--1.37, P = 0.77\] and recessive models \[TT vs. CC + TC: OR = 1.17, 95% CI: 0.88--1.54, P = 0.28\] ([Fig. 2](#f0010){ref-type="fig"}).

7.2. PSMA6 gene polymorphism with the susceptibility of IS {#s0050}
----------------------------------------------------------

For PSMA6-C8G genetic polymorphism, two case--control studies with a total of 713 IS patients and 948 controls showed a non-significant association with susceptibility to IS under dominant model \[GG + GC vs. CC: OR = 0.35, 95% CI: 0.08--1.54, P = 0.16\] and a protective level of association with the recessive model \[GG vs. CC + GC: OR = 0.25, 95% CI: 0.08--0.72, P = 0.01\] ([Fig. 2](#f0010){ref-type="fig"}).

7.3. LGALS2 gene polymorphism with the susceptibility of IS {#s0055}
-----------------------------------------------------------

For LGALS2-C2379T genetic polymorphism, two case--control studies with a total of 986 IS patients and 1039 controls showed a non-significant association with susceptibility to IS under dominant \[TT + CT vs. CC: OR = 0.29, 95% CI: 0.02--4.26, P = 0.37\] and recessive models \[TT vs. CC + TC: OR = 0.44, 95% CI: 0.09--2.09, P = 0.30\] ([Fig. 2](#f0010){ref-type="fig"}).

7.4. CD14 gene polymorphism with the susceptibility of IS {#s0060}
---------------------------------------------------------

For CD14-C260T genetic polymorphism, six case-control studies with a total of 1358 IS patients and 1423 controls showed a non-significant association with susceptibility to IS under dominant \[TT + TC vs. CC: OR = 0.93, 95% CI: 0.77--1.11, P = 0. 42\] and recessive models \[TT vs. CC + TC: OR = 1.02, 95% CI: 0.86--1.21, P = 0. 81\] ([Fig. 2](#f0010){ref-type="fig"}).

8. Discussion {#s0065}
=============

In our comprehensive meta-analysis, five SNPs of four genes involving 21 studies with 6216 IS cases and 6539 controls were analyzed. Our findings suggest that the variants in the inflammatory genes did not show any significant association with the risk of IS. No significant association was observed under both dominant and recessive models of IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and dominant model of PSMA6 (-C8G) gene polymorphisms with the risk of IS. However, the recessive model of PSMA6 (-C8G) gene polymorphism showed a protective level of association with susceptibility to IS. Our findings are consistent with the recently published meta-analysis of IL-1α showing no significant association with the risk of IS for C511T, however [@bb0150] concluded that IL-1α (-C889T) was found to be associated with the risk of IS ([@bb0150]). Previous meta-analysis by [@bb0125] also showed no association for IL-1α (C889T and C511T) with the risk of IS in overall population. But, T allele of IL-1α C511T showed a 1.97 fold risk of IS in Polish population compared with the control group. It may be possible that the effect of IL-1α C511T polymorphism on IS risk might be modified by age or other unknown factors ([@bb0125]). Meta-analysis published by [@bb0100] suggested that CD14 (-C-260T) polymorphism is a risk factor of coronary heart disease (CHD), especially in East Asians ([@bb0100]).

Our meta-analysis is the first meta-analysis to report the association of inflammatory gene polymorphisms with the risk of IS to the best of our knowledge. Overall findings did not observe any significant association between IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and PSMA6 (-C8G) gene polymorphisms and risk of IS. The present meta-analysis must be interpreted with caution because of certain limitations. First, the studies included in meta-analysis were varied in ethnicity, age and environmental factors. Second, the use of different methodologies for genotyping method, selection of controls and matching criteria may have lead to heterogeneity. Therefore, more credible evidences are required to illustrate solid conclusions on the association between inflammatory gene polymorphisms and risk of IS.

In summary, our meta-analysis shows that IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and gene polymorphisms are not significantly associated with the risk of IS while PSMA6 (-C8G) gene polymorphism may play a protective role with the susceptibility of IS. Further prospective large epidemiological studies are needed to confirm these findings.
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![Flow diagram of the selection of studies and specific reasons for exclusion from the present meta-analysis.](gr1){#f0005}

###### 

Forest plot for the association between (1) IL1α-C889T, (2) IL1α-C511T, (3) PSMA6-C8G, (4) LGALS2-C3279T and (5) CD14-C260T gene polymorphisms and IS risk under (A) dominant model, (B) recessive model.
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![Begg\'s funnel plot for assessing publication bias for (1) IL1α-C889T, (2) IL1α-C511T, (3) PSMA6- C8G, (4) LGALS2-C3279T and (5) CD14-C260T gene polymorphisms.](gr3){#f0015}

###### 

Scale for quality assessment.

  Criteria                                                                 Score
  ------------------------------------------------------------------------ -------
  *Representativeness of cases*                                            
  Selected from any population disease registry or multiple center sites   2
  Selected from any cardiology/neurology                                   1
  Not described                                                            0
                                                                           
  *Source of controls*                                                     
  Population or neighbor based                                             3
  Hospital based                                                           2
  Healthy volunteers with total description                                1
  Healthy volunteers without total description                             0.5
  Not described                                                            0
                                                                           
  *Matching of controls*                                                   
  Age & sex match                                                          2
  Smoking, hypertensive, diabetics                                         1
  Not matched                                                              0
                                                                           
  *Ascertainment of IS*                                                    
  Adequate confirmation                                                    2
  Diagnosis of IS by patient medical record                                1
  Not described                                                            0
                                                                           
  *Ascertainment of controls*                                              
  Stroke frees status by using appropriate QVSS or CT/MRI                  1
  Not described                                                            0
                                                                           
  *Genotyping*                                                             
  Genotyping done under blinded conditions                                 1
  Unblinded or not mentioned                                               0
                                                                           
  *Genotyping method*                                                      
  DNA sequencing/multiplex PCR                                             2
  PCR-RFLP                                                                 1
  Others                                                                   0
                                                                           
  *HWE*                                                                    
  Allelic frequency in accordance HWE                                      2
  Not HWE but followed statistics to adjust confounding                    1
  Not checked                                                              0
                                                                           
  *Association assessment*                                                 
  Appropriate statistics and examining confounders and effect modifiers    1
  Inappropriate statistics used Inappropriate statistics used              0
  Total score                                                              16

###### 

Characteristic of studies included in the meta-analysis of the association of TNF-α gene polymorphism with the risk of ischemic stroke.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  S. no   Author, year                     Origin    Ethnicity   Sample size case(N)/\   Gene polymorphism   Variant       PCR-method                                      Matching criteria        M/F\            Age\            HWE   Source of control   Quality score
                                                                 control(N)                                                                                                                         Case M/F\       Case/\                                    
                                                                                                                                                                                                    Control M/F     control                                   
  ------- -------------------------------- --------- ----------- ----------------------- ------------------- ------------- ----------------------------------------------- ------------------------ --------------- --------------- ----- ------------------- ---------------
  1\.     Banerjee I, 2008([@bb0010])      India     Asian       112/212                 IL-1α PSMA6         C889T 8C/G    PCR-RFLP                                        Age--sex and geography   72/40\          58.6 ± 14.2\    Yes   HB                  10
                                                                                                                                                                                                    143/69          57.4 ± 8.8                                

  2\.     Olsson S, 2012([@bb0090])        Sweden    Caucasian   844/668                 IL-1α               C889T C511T   NA                                              Age--sex                 554/290\        59 (51--64)\    Yes   PB                  12
                                                                                                                                                                                                    392/276         58 (50--64)                               

  3\.     Li N, 2010([@bb0070])            China     Asian       371/371                 IL-1α               C889T C511T   PCR-RFLP                                        NA                       230/141\        63.88 ± 7.36\   Yes   PB                  12
                                                                                                                                                                                                    247/124         62.87 ± 7.57                              

  4\.     Zhao J, 2012([@bb0145])          China     Asian       682/598                 IL-1α               C889T         PCR-RFLP                                        Age--sex                 403/279\        62.09 ± 9.43\   Yes   HB                  13
                                                                                                                                                                                                    336/262         61.84 ± 10.12                             

  5\.     Zhang Z, 2013([@bb0140])         China     Asian       440/486                 IL-1α               C889T C511T   PCR-sequencing                                  Age--sex                 291/149\        66.6 ± 8.4\     Yes   HB                  13
                                                                                                                                                                                                    314/172         66.1 ± 5.2                                

  6\.     Zee RYL, 2008 ([@bb0135])        USA       Caucasian   258/258                 IL-1α               C511T         ABI fluorescence-based allelic discrimination   Age--smoking             Geography       62.1 ± 0.5\     Yes   PB                  11
                                                                                                                                                                                                                    61.7 ± 0.5                                

  7\.     Um JY, 2003 ([@bb0115])          Korea     Asian       360/519                 IL-1α               C889T         PCR-RFLP                                        Age--sex                 177/183\        61.0 ± 14.5\    Yes   HB                  10
                                                                                                                                                                                                    250/269         62.2 ± 9.8                                

  8\.     Lai J, 2006                      China     Asian       112/95                  IL-1α               C511T         PCR-RFLP                                        Geography                72/40\          56.9 ± 13.1\    Yes   PB                  11
                                                                                                                                                                                                    60/35           57.4 ± 10.0                               

  9\.     Dziedzic T, 2005 (a)             Poland    Caucasian   122/227                 IL-1α               C511T         PCR-RFLP                                        Age--sex                 66/56\          63.2 ± 12.4\    Yes   HB                  12
                                                                                                                                                                                                    123/104         62.8 ± 12.4                               

  10\.    Dziedzic T, 2005 (b)             Poland    Caucasian   221/219                 IL-1α               C511T         PCR-RFLP                                        Age--sex                 91/130\         70.4 ± 13.1\    Yes   HB                  12
                                                                                                                                                                                                    94/125          69.2 ± 13.0                               

  11\.    Rubattu S, 2005                  Italy     Caucasian   115/180                 IL-1α               C511T         PCR-RFLP                                        Age                      51/64\          35.95 ± 8.12\   Yes   PB                  12
                                                                                                                                                                                                    98/82           34.7 ± 6.9                                

  12\.    Lacoviello L, 2005               Italy     Caucasian   134/134                 IL-1α               C511T         DNA sequencing                                  Age--sex                 69/65\          35 ± 7\         Yes   PB                  15
                                                                                                                                                                                                    65/65           35 ± 8                                    

  13\.    Seripa D, 2003                   Italy     Caucasian   101/110                 IL-1α               C511T         PCR-RFLP                                        Age                      51/50 60/50     65.8 ± 10.4\    Yes   PB                  12
                                                                                                                                                                                                                    63.7 ± 14.0                               

  14\.    Freilinger T, 2009 ([@bb0035])   Germany   Caucasian   601/736                 PSMA6 LGALS2        8C/G C3279T   MALDI-TOF mass spectrometry                     Age--sex                 377/−\          64/−\           Yes   HB                  10
                                                                                                                                                                                                     447/−           62/−                                     

  15\.    Szolnoki Z, 2009 ([@bb0105])     Hungary   Caucasian   385/303                 LGALS2              C3279T        PCR-RFLP                                        NA                       222/163\        67.4 ± 13.65\   Yes   HB                  9
                                                                                                                                                                                                    201/102         57.4 ± 14.3                               

  16\.    Lin TM, 2008 ([@bb0080])         Taiwan    Asian       450/450                 CD14                C260T         PCR-RFLP                                        Age--sex                 248/202\        64.2 ± 12.7\    No    PB                  10
                                                                                                                                                                                                    252/198         63.2 ± 12.3                               

  17\.    Lichy C, 2002 ([@bb0075])        Germany   Caucasian   151/149                 CD14                C260T         PCR-RFLP                                        Age-sex                  107/44 109/40   59.7 ± 10.8\    No    PB                  10
                                                                                                                                                                                                                    58.1 ± 10.1                               

  18\.    Zee RYL, 2002([@bb0130])         USA       Caucasian   338/338                 CD14                C260T         PCR-FRLP                                        Age--smoking             NA              61.0 ± 8.3\     Yes   HB                  11
                                                                                                                                                                                                                    60.5 ± 8.2                                

  19\.    Ito D, 2000 ([@bb0050])          Japan     Asian       235/309                 CD14                C260T         PCR-RFLP                                        Age--sex                 183/52\         58.3 ± 7.8\     No    HB                  9
                                                                                                                                                                                                    238/71          58. ± 64.4                                

  20\.    Kis Z, 2007 ([@bb0065])          Hungary   Caucasian   59/52                   CD14                C260T         Nested PCR                                      NA                       38/21\          52.8\           No    HB                  8
                                                                                                                                                                                                    26/26           50.4                                      

  21\.    Park MH, 2006                    Korea     Asian       125/125                 CD14                C260T         PCR-RFLP                                        Age--sex                 63/62\          66.74 ± 7.69\   Yes   HB                  13
                                                                                                                                                                                                    63/62           66.84 ± 7.86                              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: PCR --- polymerase chain reaction; RFLP --- restriction fragment length polymorphism; M --- male; F --- female; NA --- not available; PB --- population based; HB --- hospital based; MALDI-TOF --- matrix assisted laser desorption ionization-time of flight; and HWE --- Hardy Weinberg equilibrium.
